SynthesisESC heart failure2025

Meta-analysis of sotagliflozin, a dual sodium-glucose-cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes.

Maria Anna Bantounou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.